The company reiterated its 2025 adjusted earnings guidance of $3 to $3.15 a share. It guided for 2025 revenue of $62 billion, compared with its previous forecast of $61 billion to $64 billion.

FDA Commissioner Marty Makary defends agency leadership in NPR interview; New long COVID-19 research links disease to chronic ...

The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...

FDA Commissioner Martin Makary discusses vaccine policy, COVID-era decisions and the erosion of trust in government health ...

FDA Commissioner Dr. Marty Makary says the agency has no plans to put a black box warning on Covid-19 vaccines. He says a ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, ...

The U.S. Food and Drug Administration has no plans to put a "black box" warning on COVID-19 vaccines, Bloomberg News reported ...

California Gov. Gavin Newsom announced the hiring of two former top officials with the U.S. Centers for Disease Control and ...

How the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) determine whether a ...

The U.S. Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines, ...

Pfizer's COVID-19 vaccine has become the first in the U.S. to receive full approval from the FDA for people ages 16 and up.

Andrew Nixon, HHS spokesperson, confirmed the FDA's investigation of the COVID-19 vaccine revealed in a recently leaked email.